Gilead Sciences, Inc. (GILD)
After hours: 07:36PM EDT
| Previous Close | 66.99 |
| Open | 67.12 |
| Bid | 66.51 x 1800 |
| Ask | 67.31 x 4000 |
| Day's Range | 66.51 - 67.27 |
| 52 Week Range | 56.56 - 73.34 |
| Volume | 4,501,244 |
| Avg. Volume | 6,240,768 |
| Market Cap | 84.306B |
| Beta (5Y Monthly) | 0.42 |
| PE Ratio (TTM) | 16.46 |
| EPS (TTM) | 4.09 |
| Earnings Date | Oct. 28, 2021 |
| Forward Dividend & Yield | 2.84 (4.22%) |
| Ex-Dividend Date | Sep. 14, 2021 |
| 1y Target Est | 76.03 |
- Motley Fool
2 High-Yielding Stocks You Can Buy and Hold for Years
If you're investing in a dividend stock, it's important to balance yield with risk. While you don't want to be too aggressive by looking for 10% dividend yields, you don't want to settle for nominal payouts either. Two stocks that pay at least 3% and are fairly safe buys over the long haul are Gilead Sciences (NASDAQ: GILD) and Campbell Soup (NYSE: CPB).
- Motley Fool
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
Earlier this month, Merck (NYSE: MRK) announced it was ending clinical trials of its antiviral pill candidate for treating COVID-19, molnupiravir, on account of the potential therapy's high level of effectiveness. Take Gilead Sciences' (NASDAQ: GILD) antiviral drug, remdesivir. Will Merck's drug follow a similar or better path?
- Zacks
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $67.24, moving +0.37% from the previous trading session.
